Given the recent advancements that have elucidated the distinct pathogenesis of primary and secondary GB transformed from low-grade glioma, which mostly presented IDH mutations, the impact of KIR gene polymorphism on the risk of secondary GB could differ from our results [60,61]. This evidence concerns the gene KIR3DL1 and glioma.